Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
JIB
GLOBETECH PUBLISHING

Regenerative Medicine Aided by Nanotechnology Strategies

By BiotechDaily International staff writers
Posted on 19 Nov 2013
Nanotechnology may provide new approaches for regenerative medicine, including better ways to restore or enhance damaged tissues, according to a review article by Taiwanese researchers.

Published October 2013 in the journal Science and Technology of Advanced Materials, the study reported on the current state of knowledge on nanotechnology with a focus on stem cell biology applications. Stem cells are an important potential source for repairing injured human tissues. Researchers have found that the adhesion, growth, and differentiation of stem cells are most probably controlled by their surrounding microenvironment, which contains both physical and chemical signals. These signals include the “nanotopography” of the complicated extracellular matrix that comprises a network for human tissues.

Dr. Yang-Kao Wang and colleagues from Taipei Medical University (Taipei City, Taiwan) described in their article studies showing how this nanotopography (which includes nanosized pores, ridges, and grooves) plays critical roles in the behavior and fate of stem cells. The authors also discussed the application of nanoparticles to stem cell isolation, tracking and imaging; how to convert nanotechnology tools from two to three dimensions; and the potential limitations of using nanomaterials in stem cell biology.

The authors concluded that “understanding [the] interactions of nanomaterials with stem cells may provide knowledge applicable to [the development of improved] cell-scaffold combinations in tissue engineering and regenerative medicine.”

Related Links:

Taipei Medical University



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Illustration of the apoER2 receptor protein shows the structure of the entire protein in detail (Photo courtesy of Wikimedia Commons).

Risk of Cardiovascular Disease Linked to Apolipoprotein E Variants

The apoE4 variant form of circulating apolipoprotein E (apoE) leads to increased risk of cardiovascular disease by blocking binding of the normal apoE3 form to the apoliprotein E receptor 2 (apoER2) in... Read more

Drug Discovery

view channel
Image: S-649266 has more robust antibacterial activity than established antibiotics against multidrug-resistant bacteria (Photo courtesy of Shionogi).

Novel Antibiotic Shows Potential for Broad Range of Infections

The emergence of bacterial resistance to known antibacterial agents is becoming a major challenge in treating the infection caused by multi drug resistant (MDR) bacteria. In order to treat bacterial... Read more

Business

view channel

Collaboration of Mayo Clinic and IBM Cognitive Computer Devised to Improve Clinical Trial Research

The Mayo Clinic (Rochester, MN, USA) and IBM (Armonk, NY, USA) recently announced plans to pilot Watson, the IBM cognitive computer, to match patients more rapidly with suitable clinical trials. A proof-of-concept phase is currently ongoing, with the intent to introduce it into clinical use in early 2015.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.